P. Rajananthanan

Leading Article Biologicals & Immunologicals: Immunological adjuvants: Mechanisms of action and clinical applications

N. Sheikh, P. Rajananthanan, W. Morrow, 1996 .

Novel aggregate structure adjuvants modulate lymphocyte proliferation and Th1 and Th2 cytokine profiles in ovalbumin immunized mice.

N. Sheikh, P. Rajananthanan, W. Morrow, 1999, Vaccine.

Differential requirements for CTL generation by novel immunostimulants: APC tropism, use of the TAP-independent processing pathway, and dependency on CD80/CD86 costimulation.

N. Van Rooijen, Ya-Wun Yang, N. Sheikh, 2003, Vaccine.

Generation of antigen specific CD8+ cytotoxic T cells following immunization with soluble protein formulated with novel glycoside adjuvants.

N. Sheikh, P. Rajananthanan, W. Morrow, 1999, Vaccine.

Donor selection

P. Rajananthanan, F. Bigey, F. Pouthier, 2004 .

Evaluation of novel aggregate structures as adjuvants: composition, toxicity studies and humoral responses.

N. Sheikh, P. Rajananthanan, W. Morrow, 1999, Vaccine.

Differential up-regulation of HLA-DM, invariant chain, and CD83 on myeloid and plasmacytoid dendritic cells from peripheral blood.

F. Borràs, P. Rajananthanan, C. Navarrete, 2004, Tissue antigens.